Press Contact: Kirsten Mabry | (617) 495-4157
Featured Tags:
April 29th, 2026
Harvard researchers have developed a 3D printing method that places “active” liquid crystal elastomers and “passive” elastomers side by side in filaments, effectively pre programming the filaments to bend, twist, expand, or contract in specific ways when heated or cooled.
April 9th, 2026
Organ Chips developed at the Wyss Institute and commercialized by Emulate were aboard NASA’s Artemis II mission. Wyss and Emulate scientists will study the Bone Marrow Chips to understand how microgravity and radiation affect the human body.
March 24th, 2026
New findings by Harvard stem cell biologists suggest it may be possible in the future to regrow wounded skin without scarring.
March 9th, 2026
A research team led by Christina Woo, professor of chemistry and chemical biology, in collaboration with a team of scientists at pharmaceutical company GSK and Scripps Research Institute, discovered a hidden binding pocket on the protein cereblon. The discovery of the allosteric cereblon binder could uncover a new area of cereblon biology to explore for cancer drugs.
March 2nd, 2026
Researchers in Andrew Kruse’s lab overcame a key obstacle in using the hormone relaxin as a therapy for heart disease. With support from Harvard’s Blavatnik Biomedical Accelerator, this discovery led to the launch of Tectonic Therapeutic, which is now testing its relaxin-based drug in clinical trials.
